X Bioscience Public Company Limited

SET:XBIO-R Stock Report

Market Cap: ฿56.9m

X Bioscience Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Saowanee Khaoubol

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3yrs
CEO ownershipn/a
Management average tenure1.6yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

CEO

Saowanee Khaoubol (50 yo)

3yrs
Tenure

Ms. Saowanee Khaoubol serves as Interim Chief Executive Officer of X Bioscience Public Company Limited (formerly known as Wow Factor Public Company Limited) and serves as its Acting Company Secretary since...

Leadership Team

NamePositionTenureCompensationOwnership
Saowanee Khaoubol
Acting Chief Executive Officer3yrsno datano data
Tanawat Ueasiripan
COO & Vice Chairman of the Board2.9yrs฿50.00kno data
Phurit Wongkham
Chief Administrative Officer & Directorno datano datano data
Wilawan Lowudomsap
Acting Chief Financial Officer1.6yrsno datano data
Michael Fernandez
Director of Investmentsno datano datano data
Ramjai Sriprommin
Chief Accountantless than a yearno datano data
Pongsak Nawalak
Director of Technologyno datano datano data
Tanapat Thongplub
Head of Compliance & Head of Internal Auditno datano datano data
Nitchanun Yammeesri
Company Secretaryless than a yearno datano data
1.6yrs
Average Tenure
47yo
Average Age

Experienced Management: XBIO-R's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Saowanee Khaoubol
Acting Chief Executive Officerno datano datano data
Tanawat Ueasiripan
COO & Vice Chairman of the Board2.9yrs฿50.00kno data
Phurit Wongkham
Chief Administrative Officer & Directorno datano datano data
Sivaporn Chomsuwan
Independent Director1.8yrs฿60.00kno data
Somboon Prasobpiboon
Independent Director2.8yrs฿50.00kno data
Naphat Tavisaengsiri
Director2.3yrs฿70.00k2.05%
THB 1.2m
Yuthaveera Achawangkul
Independent Directorno data฿130.00kno data
Tom Chalermkarnchana
Independent Director2yrs฿120.00kno data
Sarayut Rueangsuwan
Independent Directorless than a yearno datano data
2.1yrs
Average Tenure
45yo
Average Age

Experienced Board: XBIO-R's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/05 12:09
End of Day Share Price 2025/11/05 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

X Bioscience Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.